Mesenchymal stem cells for treatment of aortic aneurysms

Table 1 Mesenchymal stem cells phenotypic characteristics

		Positive marker	Negative marker	Pluripotency	Ref.
ISCT criteria	Human MSC	CD73, CD90, CD105	CD34, CD45, CD11b or CD14, CD19 or CD79α, HLA-DR	Osteogenic Chondrogenic Adipogenic	[38]
In AA experimental studies	Mouse BM-MSC	CD44, CD106, Sca-1	CD11b, CD31, CD34, CD45, CD86, CD117	Osteogenic Chondrogenic Adipogenic	[51,53]
	Human placental-MSC	CD29, CD44, CD73, CD90, CD105	CD14, CD19, CD34, CD45, HLA-DR	Data not shown	[54]
	Rat BM-MSC	CD44, CD73, CD90, CD105	CD11b, CD45	Data not shown	[56]
	Pig ASC	CD73, CD90, CD105	CD14, CD11b	Osteogenic Chondrogenic Adipogenic	[57]
	Pig BM-MSC	CD13, CD29	CD31, CD34, CD45	Data not shown	[58]

ISCT: International society of cell therapy; MSC: Mesenchymal stem cell; AA: Aortic aneurysm; BM-MSC: Bone marrow-derived MSC; HLA-DR: Human leukocyte antigen-DR; ASC: Adipose tissue-derived MSC.